Rizwan Haq

Oncology

450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Oncogenic Gα signaling requires AP-3-dependent recruitment to the endolysosomal compartment.

Oncogenic Gα signaling requires AP-3-dependent recruitment to the endolysosomal compartment.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 22, 2026

Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025.

Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025.

Journal: Pigment cell & melanoma research

Published: April 13, 2026

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

Journal: CA: a cancer journal for clinicians

Published: February 13, 2026

Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.

Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.

Journal: Molecular cancer therapeutics

Published: December 05, 2025

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.

Journal: Cancer cell

Published: June 10, 2025

Immunotherapy Rechallenge Is Effective for Most Patients With Late Progression After Initial Ipilimumab + Nivolumab Response.

Immunotherapy Rechallenge Is Effective for Most Patients With Late Progression After Initial Ipilimumab + Nivolumab Response.

Journal: Pigment cell & melanoma research

Published: April 20, 2025

Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanoma.

Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanoma.

Journal: bioRxiv : the preprint server for biology

Published: February 20, 2025

"Re-re-treatment?" Third and fourth courses of BRAF/MEK inhibition in advanced melanoma.

"Re-re-treatment?" Third and fourth courses of BRAF/MEK inhibition in advanced melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 13, 2025

Severity and progression of dermatologic adverse events associated with tebentafusp: A retrospective multicenter cohort study.

Severity and progression of dermatologic adverse events associated with tebentafusp: A retrospective multicenter cohort study.

Journal: Journal of the American Academy of Dermatology

Published: January 08, 2025

Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.

Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.

Journal: Science advances

Published: November 27, 2024

Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab.

Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab.

Journal: Journal for immunotherapy of cancer

Published: August 06, 2024

Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.

Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.

Journal: Pigment cell & melanoma research

Published: June 19, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026